Tamoxifen

Dec 05, 2019

Apotex Releases New Supply of Tamoxifen Into Canadian Market

Nov 20, 2019

Information Update - Health Canada update on the tamoxifen shortage

Jun 01, 2019

Novartis Kisqali significantly extends life in women with HR+/HER2- advanced breast cancer in MONALEESA-7 trial

May 22, 2019

United States $20 Bn Breast Cancer Drug Market to 2025: 42 Marketed Drugs, 317 Drugs in Clinical Pipeline by Company, Phase, Drug Class & Patient Segment

Apr 11, 2019

Biotechs Strive to Provide Patients With More Affordable Treatment Options

Mar 14, 2019

New Potential Treatment Option For Hot Flash Relief For Menopausal Women And Women Taking Tamoxifen®

Jan 03, 2018

Novartis Kisqali® received FDA Breakthrough Therapy designation for initial endocrine-based treatment in premenopausal women with HR+/HER2- advanced breast cancer

Dec 29, 2017

ANI Pharmaceuticals Acquires Four NDAs from AstraZeneca for $46.5 Million

Dec 05, 2017

Cancer Discovery in Novel Seaweed Extracts

Oct 17, 2017

Tamoxifen Citrate Market 2017-2022 Global Trends and Future Insights

Oct 02, 2017

The Breast Cancer Research Foundation Commits $59.5 Million to Fund Cancer Research Worldwide